SCOTTSDALE, Ariz., July 1, 2009 (GLOBE NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), a leading provider of technology solutions and the market leader in electronic control devices (ECDs), announces its first major new handheld ECD since the launch of the TASER(r) X26(tm) in 2003. The new TASER X3(tm) features a revolutionary technology called the Rotational Pulse Drive, which creates the first multi-shot ECD capable of simultaneously incapacitating multiple targets.
The TASER X3 will be unveiled at the annual TASER Conference on July 27 in Fountain Hills, Arizona. Press and media are encouraged to attend this momentous event at the opening of the conference.
No complete images of the X3 will be released prior the TASER Conference on July 27. However, each day from July 1 through July 27, the new X3 website at www.TASERX3.com will reveal never-before-seen X3 technology and features. TASER also invites interested parties to follow the X3 through its Internet persona on Twitter at www.Twitter.com/TASERX3 and on Facebook(r) at www.Facebook.com/TASERX3 for additional information and insights leading up to the official launch.
"The TASER X3 is the product of our commitment to keep breaking the barriers of what's technologically possible," said Rick Smith, CEO and founder of TASER International. "The X3 is the culmination of over four years of intense research and development and offers exponentially increased capabilities, including vastly enhanced data, networking, and communication functionality as well as enhanced safety features. Our customers and shareholders know the company has made major investments over the past 24 months to bring a host of new products to market -- including the AXON(tm) Tactical Computer, EVIDENCE.COM(tm), and the long awaited wireless TASER(r) eXtended Range Electronic Projectile (XREP(tm)) shotgun rounds announced just yesterday. Our R&D Team has secretly worked on a parallel path to bring the X3 to reality. Together, these innovative developments create an ecosystem of technologies that interface together to provide law enforcement never-before-possible, breakthrough capabilities. The TASER(r) product family will provide our customers smarter safer capabilities to better protect our officers and our communities," concluded Smith.
More information on the TASER X3 is available at: www.TASERX3.com.
Photos, pricing, upgrade programs and availability of the TASER X3 will be available July 27.
Follow the daily release of features and updates at: www.TASERX3.com, www.Twitter.com/TASERX3, and www.Facebook.com/TASERX3.
About TASER International, Inc.
TASER International's products protect life. TASER provides advanced Electronic Control Devices (ECDs) for use in the law enforcement, medical, military, corrections, professional security, and personal protection markets. TASER devices use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. For more information, please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.
The TASER International logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2931
For more information on commercial, special purpose, law enforcement and military shotguns, rifles and accessories, please call your local Mossberg dealer or visit Mossberg online at www.mossberg.com.
Note to Investors
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.
The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.